Outlook

For the fiscal year 2023/24 WSA expects 7-10% organic revenue growth (upward adjustment at Q1 from 6-10% organic growth) driven by core markets (US, France, Germany) supported by the launch of Signia IX and continued growth in fast growing markets, US Managed Care and online. The reported EBITDA margin is expected to increase by 1-2%-pts. vs. FY 2022/23 supported by revenue growth and cost improvement initiatives.